OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $348,007 Invested

2026

Washington University in St. Louis

Timothy Miller, MD, PhD

Optimizing a Gene-Targeted Therapeutic to Enhance TBK1 Expression in Genetic FTD

  • Funding Amount: $348,007
  • Organization Type:
  • Program: Drug Discovery
  • Target: Other
  • Status: Active